TLCR’s Special Issue dedicated to the 14^th Central European Lung Cancer Congress (CELCC)

Co-edited by Prof. Robert Pirker from Austria and Prof. Caicun Zhou from China, Translational Lung Cancer Research (TLCR) in October has successfully published a special issue (Vol 3, No 5) (Figure 1) dedicated to the 14^th Central European Lung Cancer Conference (CELCC) held in Vienna, Austria, from 29 November until 2 December 2014.

Figure 1 Vol 3, No 5 (October, 2014).

The CELCCs have a long tradition and have been regularly held in various cities of Central Europe since 1992. Besides focusing on molecular diagnosis and targeted therapies, this year’s Conference will also have a session on the implementation of screening and a special Chinese-Central European Symposium. Our editorial staffs are going to attend the 14^th CELCC in Vienna to better exhibit our journals. We welcome you to visit us at exhibit booth (Figure 2) for free copies and giveaways.

Figure 2 Exhibition Floor Plan: the exhibition booth of AME/PBPC Publishing Company is near the entrance of Landtagssaal.

This special issue of TLCR dedicated to the 14^th CELCC, covers timely topics with regard to diagnosis and treatment of lung cancer, and also contains the abstracts submitted for presentations during the 14^th CELCC. The full content of the special issue is available via: http://www.tlcr.org/issue/view/112.

We hope that the Conference and the special issue will meet your scientific and educational needs.

Table of Contents for the special issue (TLCR Vol 3, No 5):

Preface

• Preface
  Robert Pirker, Caicun Zhou

Review Article

• Lung cancer molecular epidemiology in China: recent trends
  Caicun Zhou

• Tobacco control in Poland—successes and challenges
  Jacek Jassem, Krzysztof Przewoźniak, Witold Zatoński

• Implementation of lung cancer screening: promises and hurdles
  Helmut Prosch

• Molecular testing in lung cancer in the era of precision medicine
  Helmut H. Popper, Ales Ryska, József Tímár, Wlodzimierz Olszewski

• Minimal requirements for the molecular testing of lung cancer
  Helmut H. Popper, József Tímár, Ales Ryska, Wlodzimierz Olszewski

• Adjuvant chemotherapy in patients with completely resected nonsmall cell lung cancer
  Robert Pirker

• Clinical trials for lung cancer in China
  Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

CELCC 2014 Abstracts

• The 14^th CELCC Conference Abstracts

Acknowledgements

Disclosure: The author declares no conflict of interest.